Structures by: Ryder K. S.
Total: 23
Compound X
C9H14O2
Org. Biomol. Chem. (2003) 1, 4 700-704
a=6.1182(3)Å b=6.6921(4)Å c=10.1810(5)Å
α=90.00° β=94.019(3)° γ=90.00°
Compound X
C10H16O
Org. Biomol. Chem. (2003) 1, 4 700-704
a=5.9714(1)Å b=20.5466(5)Å c=22.5632(6)Å
α=90.00° β=90.00° γ=90.00°
Compound X
C10H16O1
Org. Biomol. Chem. (2003) 1, 4 700-704
a=10.7633(1)Å b=10.7633(1)Å c=31.3398(5)Å
α=90.00° β=90.00° γ=90.00°
C19H18N4O3
C19H18N4O3
Journal of Materials Chemistry (2002) 12, 3 579
a=11.8709(18)Å b=7.6449(12)Å c=20.891(4)Å
α=90.00° β=111.696(3)° γ=90.00°
C20H18N4O
C20H18N4O
Journal of Materials Chemistry (2002) 12, 3 579
a=9.5009(6)Å b=13.9016(9)Å c=14.6728(10)Å
α=66.442(2)° β=81.618(2)° γ=81.938(2)°
(C40H36Cl2Ir2N8O4)8(H2O)
(C40H36Cl2Ir2N8O4)8(H2O)
Dalton transactions (Cambridge, England : 2003) (2011) 40, 5 1028-1030
a=15.880(10)Å b=19.871(12)Å c=29.233(18)Å
α=90.00° β=90.00° γ=90.00°
(C30H23BrF6IrN6P)(CH2Cl2)
(C30H23BrF6IrN6P)(CH2Cl2)
Dalton transactions (Cambridge, England : 2003) (2014) 43, 10 4026-4039
a=12.112(2)Å b=17.706(3)Å c=16.566(3)Å
α=90.00° β=106.849(3)° γ=90.00°
C34H31BrIrN6,F6P
C34H31BrIrN6,F6P
Dalton transactions (Cambridge, England : 2003) (2014) 43, 10 4026-4039
a=8.7123(17)Å b=20.055(4)Å c=18.908(4)Å
α=90.00° β=92.520(4)° γ=90.00°
(C32H27BrIrN6)(PF6)0.5(CH2Cl2)0.5(C2H6O)0.5(C6H14)
(C32H27BrIrN6)(PF6)0.5(CH2Cl2)0.5(C2H6O)0.5(C6H14)
Dalton transactions (Cambridge, England : 2003) (2014) 43, 10 4026-4039
a=10.898(2)Å b=12.910(3)Å c=27.523(6)Å
α=90.069(4)° β=98.453(4)° γ=97.286(4)°
C30H24IrN6,F6P,CHCl3
C30H24IrN6,F6P,CHCl3
Dalton transactions (Cambridge, England : 2003) (2014) 43, 10 4026-4039
a=8.6792(13)Å b=13.646(2)Å c=14.054(2)Å
α=89.021(3)° β=82.419(3)° γ=88.401(3)°
C27H26IrN6,F6P,CH2Cl2
C27H26IrN6,F6P,CH2Cl2
Dalton transactions (Cambridge, England : 2003) (2014) 43, 10 4026-4039
a=13.521(3)Å b=26.046(6)Å c=8.728(2)Å
α=90.00° β=90.00° γ=90.00°
(C31H24IrN6O2,F6P,2H2O)
(C31H24IrN6O2,F6P,2H2O)
Dalton transactions (Cambridge, England : 2003) (2014) 43, 10 4026-4039
a=9.6561(16)Å b=11.621(2)Å c=15.632(3)Å
α=105.756(3)° β=99.890(3)° γ=99.000(3)°
C28H26IrN6O2,F6P,2(CH2Cl2)
C28H26IrN6O2,F6P,2(CH2Cl2)
Dalton transactions (Cambridge, England : 2003) (2014) 43, 10 4026-4039
a=14.172(3)Å b=15.658(3)Å c=16.259(4)Å
α=90.00° β=97.643(4)° γ=90.00°
1,2,5,6,dibenzofluorenone
C21H12O
Acta Crystallographica Section C (1998) 54, 10 1542-1544
a=13.002(9)Å b=9.329(6)Å c=22.798(14)Å
α=90.00° β=95.21(5)° γ=90.00°
10-bornanesulfonic acid 2-hydroxy-γ-sultone
C10H16O3S
Acta Crystallographica Section C (1998) 54, 10 1546-1548
a=10.5933(6)Å b=8.8517(7)Å c=11.3495(6)Å
α=90.00° β=91.606(4)° γ=90.00°
9-methylfluoren-9-ol
C14H12O
Acta Crystallographica Section C (2002) 58, 10 o615-o618
a=9.2540(2)Å b=11.4154(4)Å c=11.8476(4)Å
α=89.1980(10)° β=116.1620(10)° γ=107.1080(10)°
9-methylfluoren-9-ol
C14H12O1
Acta Crystallographica Section C (2002) 58, 10 o615-o618
a=8.7380(2)Å b=11.4571(3)Å c=11.7097(4)Å
α=90.952(2)° β=103.4620(10)° γ=106.2250(10)°
C16H14O1
C16H14O1
Acta Crystallographica Section C (2003) 59, 6 o283-o285
a=14.3719(3)Å b=22.8650(6)Å c=7.07030(10)Å
α=90° β=90° γ=90°
1,2,7,8 dibenzofluorenone
C21H12O
Acta Crystallographica Section C (2000) 56, 5 570-571
a=13.2543(9)Å b=25.7694(18)Å c=3.8521(2)Å
α=90.00° β=90.00° γ=90.00°
C18H15N1O4S2
C18H15N1O4S2
Acta Crystallographica Section C (2003) 59, 7 o376-o377
a=8.9402(2)Å b=17.2777(5)Å c=11.3437(4)Å
α=90° β=90° γ=90°
C19H15NS2
C19H15NS2
Acta Crystallographica Section C (2004) 60, 3 o166-o168
a=16.8050(8)Å b=10.0004(5)Å c=18.6253(9)Å
α=90° β=95.241(2)° γ=90°
C19H42N2O2S1
C19H42N2O2S1
Crystal Growth & Design (2005) 5, 1 361
a=5.6334(5)Å b=39.286(3)Å c=9.6819(6)Å
α=90° β=91.276(7)° γ=90°
C26H22N4NiO2,2(C2H6O2),2(Cl)
C26H22N4NiO2,2(C2H6O2),2(Cl)
Inorganic chemistry (2014) 53, 12 6280-6288
a=12.133(3)Å b=12.283(3)Å c=13.281(3)Å
α=63.674(4)° β=63.441(4)° γ=60.698(5)°